Cargando…
Establishment of a Novel PDX Mouse Model and Evaluation of the Tumor Suppression Efficacy of Bortezomib Against Liposarcoma
The patient-derived xenograft (PDX) model has been adopted as a major tool for studying tumorigenesis and differentiation in various carcinomas. In addition, it has been used in the development of anticancer agents. PDX models have been among the most meaningful tools used to understand the role of...
Autores principales: | Jo, Eun Byeol, Hong, Doopyo, Lee, Young Sang, Lee, Hyunjoo, Park, Jae Berm, Kim, Sung Joo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260470/ https://www.ncbi.nlm.nih.gov/pubmed/30447641 http://dx.doi.org/10.1016/j.tranon.2018.09.015 |
Ejemplares similares
-
Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells
por: Jo, Eun Byeol, et al.
Publicado: (2019) -
Overexpression of Replication-Dependent Histone Signifies a Subset of Dedifferentiated Liposarcoma with Increased Aggressiveness
por: Yoo, Yongjin, et al.
Publicado: (2021) -
CDK4 Amplification Predicts Recurrence of Well-Differentiated Liposarcoma of the Abdomen
por: Lee, Sanghoon, et al.
Publicado: (2014) -
Establishment and Characterization of Humanized Mouse NPC-PDX Model for Testing Immunotherapy
por: Liu, Wai Nam, et al.
Publicado: (2020) -
Maximum standardized uptake value on (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improves outcome prediction in retroperitoneal liposarcoma
por: Rhu, Jinsoo, et al.
Publicado: (2019)